Phio Pharmaceuticals (PHIO) Net Margin (QoQ) (2012 - 2018)
Phio Pharmaceuticals (PHIO) Net Margin (QoQ) (2012 - 2018) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.99 Bn | 132.14 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 86.80 Bn | 78.80 Bn | 3.93 Bn |
| 3 | Argenx Se | 65.38 Bn | 60.19 Bn | 1.37 Bn |
| 4 | Moderna | 60.70 Bn | 55.56 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 42.22 Bn | 37.12 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.67 Bn | 28.36 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.45 Bn | 10.06 Bn | 668.28 Mn |
| 8 | Insmed | 27.47 Bn | 26.31 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.21 Bn | 26.37 Bn | - |
| 10 | Phio Pharmaceuticals | 14.11 Mn | 14.11 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2018 | 65,829.00 |
| Jun 30, 2018 | 645,720.00 |
| Mar 31, 2018 | 1.44 Mn |
| Jun 30, 2016 | -226,778.00 |
| Mar 31, 2015 | 1.06 Mn |
| Dec 31, 2014 | -159,464.00 |
| Sep 30, 2014 | 866,250.00 |
| Jun 30, 2014 | -1.29 Mn |
| Mar 31, 2014 | -108,276.00 |
| Dec 31, 2013 | -903,396.00 |
| Sep 30, 2013 | -187,309.00 |
| Jun 30, 2013 | 3.19 Mn |
| Mar 31, 2013 | -2.73 Mn |
| Dec 31, 2012 | -145,044.00 |